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Abstract. Adipocytes are the main stromal cells in the 
mammary microenvironment, and crosstalk between adipo‑
cytes and breast cancer cells may play a critical and important 
role in cancer maintenance and progression. Tumor‑induced 
differentiation to beige/brown adipose tissue is an important 
contribution to the hypermetabolic state of breast cancer. 
However, the effect of epithelial cell‑beige adipocyte commu‑
nication on tumor progression remains unclear. To contribute 
to the understanding of this phenomenon, we characterized 
components present in conditioned media (CM) from beige 
adipocytes (BAs) or white adipocytes (WAs), and evaluated 
the effects of BA‑ and WA‑CM on both adhesion and migration 
of tumor (LM3, 4T1 and MC4‑L1) and non‑tumor (NMuMG) 
mouse mammary epithelial cell lines. Additionally, we 
analyzed the expression of ObR, CD44, vimentin, MMP‑9, 
MCT1 and LDH in tumor and non‑tumor mouse mammary 
epithelial cell lines incubated with BA‑CM, WA‑CM or 
Ctrol‑CM (control conditioned media). 3T3‑L1 preadipocytes 
differentiated into beige adipocytes upon PPARγ activation 
(rosiglitazone) displaying characteristics that morphologically 
resembled brown/beige adipocytes. Levels of UCP1, CIDEA, 
GLUT4, leptin, MCT4 and FABP4 were increased, while 
adiponectin, caveolin 1 and perilipin 1 levels were decreased 
in BAs with respect to WAs. Tumor cell lines revealed lower 
cell adhesion and increased cell migration after incubation 
with BA‑ and WA‑CM vs. Ctrol‑CM. ObR and MMP‑9 in 
MC4‑L1 cells were significantly increased after incubation 
with BA‑CM vs. WA‑ and Ctrol‑CM. In addition, MC4‑L1 
and LM3 cells significantly increased their migration in the 
presence of BAs, suggesting that new signals originating 
from the crosstalk between BAs and tumor cells, could be 
responsible for this change. Our results indicate that beige 
adipocytes are able to regulate the behavior of both tumor and 
non‑tumor mouse mammary epithelial cells, favoring tumor 
progression.
Introduction
Tumor progression depends on the influence of not only 
tumor cells but also surrounding stromal tissue (1), where 
adipocytes are the main cellular component and thus consti‑
tute the main part of the breast cancer microenvironment. 
After interacting with breast cancer cells, adipocytes are 
converted into cancer‑associated adipocytes (CAAs) and, as 
such, promote tumor progression (2‑4). There is emerging 
evidence indicating that adipocytes enhance tumor progres‑
sion by mutual and dynamic cross‑communication with tumor 
cells (5). Adipocytes, as well‑known endocrine cells, produce 
several inflammatory factors, growth factors and cytokines 
which, in turn, stimulate receptor tyrosine kinase downstream 
signaling and programs for epithelial mesenchymal transition 
(EMT) (6,7). Specifically, tumors may turn a normal stroma 
into an advantageous microenvironment by different means, 
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such as promoting a wound healing response or the metabolic 
reprogramming of adipocytes (8,9).
From a histological and functional point of view, two 
types of adipose tissue have been distinguished, white and 
brown (10). White adipose tissue (WAT) is composed of cells 
specialized to store excess energy, as evidenced by the presence 
of one large lipid droplet (LD) (unilocular adipocyte) filled up 
with triglycerides (TGs), and characterized by an extremely 
low oxidative capacity, as a consequence of a small number 
of thin and elongated mitochondria (11). In contrast, brown 
adipose tissue (BAT) converts excess energy into heat through 
uncoupled respiration depending, in part, on the expression of 
uncoupling protein 1 (UCP1) (10,12). WAT does not normally 
express UCP1; nevertheless, clusters of UCP1‑expressing 
adipocytes (named beige or ‘brite’, as in brown in white) 
with thermogenic capacity develop within WAT in response 
to various stimuli (13). Beige adipocytes within WAT are 
defined by the morphology of the multilocular and small lipid 
droplets, a high mitochondrial content and the expression of a 
set of brown fat‑specific genes [for example, Ucp1, Cidea (cell 
death‑inducing DFFA‑like effector A) and Pgc1α (peroxisome 
proliferator activated receptor‑γ coactivator 1‑α)].
In the breast, WAT is present continuously from birth 
to adulthood, whereas BAT often has a temporary appear‑
ance (14,15). Knowledge of the contribution of brown/beige 
adipose cells to mammary gland physiology and how its 
temporary appearance is regulated is rather limited.
Recent studies have associated brown adipocytes with 
breast cancer (16‑19). BAT secretes diverse soluble factors, 
(‘batokines’), expresses high levels of glucose transporter 4 
(GLUT4) and consumes higher levels of glucose (20). Using 
18F‑labeled fluorodeoxyglucose positron emission tomog‑
raphy/computerized tomography (PET/CT), a high prevalence 
of BAT activity was found in breast cancer patients when 
compared to a weight‑matched cohort of patients with other 
solid tumor malignancies (16). Additionally, a persistent 
deposition of brown adipose cells has been observed in the 
mammary glands of BRCA1‑mutant mice (17) and a higher 
browning of mammary fat has been reported close to 
malignant tumors compared to the vicinity of benign breast 
lesions (19,21). Wu et al postulated that the preliminary step 
towards a tumor‑adipocyte crosstalk is the ability of tumor 
cells to induce beige/brown differentiation as well as a lipo‑
lytic process in adipocytes (19). In this context, the question 
arises as to whether beige adipocytes could be new and key 
actors in breast cancer development and maintenance of a 
cancerous phenotype. In other words, can beige adipocytes 
indeed modify the behavior of epithelial breast cancer cells?
Herein, we attempted to determine the effects of 
brown/beige adipose cells on adhesion and migration, key 
processes in tumor progression. For this purpose, 3T3‑L1 
adipocytes differentiated in the presence of rosiglitazone, a 
strong inducer of white to brown fat conversion, were used as 
a model of murine beige adipocytes. Soluble and non‑soluble 
components present in beige adipocytes (BAs), were identified 
and compared with those present in white adipocytes (WAs) 
by indirect immunofluorescence, RT‑qPCR and western blot 
analysis. The effect of soluble factors released by WAs and 
BAs on adhesion and migration of NMuMG (non‑tumor) and 
LM3, 4T1 and MC4‑L1 (tumor) mouse mammary epithelial 
cell lines was studied using WA‑ or BA‑conditioned media 
(CM). Factors whose levels are modified in mammary cell 
lines (non‑tumor and tumor) following incubation with BA‑ or 
WA‑CM for 24 h were evaluated; particularly leptin receptor 
(ObR), CD44, vimentin and matrix metalloprotease (MMP)‑9 
(tumor progression markers in epithelial cells) and mono‑
carboxylate transporter (MCT)1 and lactate dehydrogenase 
(LDH) (metabolic markers).
The present study provides significant evidence that BAs 
could promote breast cancer progression in a murine in vitro 
model. However, the physiological importance of beige adipose 
cells in tumor microenvironment and the regulation of breast 
cancer cell behavior, remain open questions.
Materials and methods
Reagents. Culture medium Dulbecco's modified Eagle's 
medium/Nutrient Mixture F12 D‑MEM/F‑12 (cat. no. 
12400‑024), trypsin‑EDTA (cat. no. 25200‑072) were 
purchased from Gibco (Thermo Fisher Scientific, Inc.); 
phenol red‑free D‑MEM/F‑12 (cat. no. 90‑090‑PBR) was 
obtained from Corning (Mediatech, Inc.); heat‑inactivated 
fetal bovine serum (FBS) from Natocor; 3‑isobutyl‑1‑methyl‑
xanthine (IBMX, cat. no. I7018), bovine serum albumin (BSA, 
cat. no. 10735086001) and dexamethasone (cat. no. D1756) 
were purchased from Sigma‑Aldrich/Merck KGaA and 
rosiglitazone (cat. no. ab120762) was from Abcam.
Culture of tumor and non‑tumor mammary cancer cells. 
Immortalized epithelial cell lines, derived from tumor (4T1, 
LM3 and MC4‑L1) and non‑tumor (NMuMG) mammary cells 
were used. Mouse metastatic mammary cancer cells 4T1 (ER‑, 
PR‑, HER2‑) and NMuMG were obtained from the American 
Type Culture Collection (ATCC). LM3 is an immortalized 
mouse metastatic mammary cell line obtained from a primary 
tumor (ER‑, PR‑, HER2+) by Urtreger et al (22). MC4‑L1 is an 
immortalized mouse metastatic mammary line obtained from 
a primary tumor (ER+, PR+) by Lanari et al (23). All cells were 
cultured in D‑MEM/F‑12 medium (cat. no. 12400‑024; Gibco; 
Thermo Fisher Scientific, Inc.) containing 10% FBS (complete 
D‑MEM/F‑12 medium) in a humidified 5% CO2 atmosphere 
at 37˚C. Every 2‑3 days, cell culture medium was removed and 
replaced by complete D‑MEM/F‑12 medium. All cells used 
were mycoplasma‑free.
Culture and differentiation of preadipocytes 3T3‑L1. Murine 
3T3‑L1 preadipocyte cells (obtained from ATCC) were grown 
in complete D‑MEM/F‑12 medium in a humidified 5% CO2 
atmosphere at 37˚C. Cells were used between passages 
12‑22; adipocyte differentiation was induced as previously 
described (24). Briefly, 3T3‑L1 preadipocytes were seeded 
in 12‑well plates and grown until confluence (day 0). Two 
days later, an adipogenic cocktail containing 0.5 mM IBMX, 
0.1 µM dexamethasone and 0.1 µM rosiglitazone was added 
and cells were cultured further for 2 days. Subsequently, culture 
medium was replaced by complete D‑MEM/F‑12 containing 
2 µM insulin until the end of the culture period, changing 
the medium every other day. After 9‑10 days, 90‑100% cells 
had differentiated into WAs, with increasing TG content 
and formation of LDs, which were visualized under light 
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microscopy either directly or following Oil Red O staining. To 
obtain BAs, 3T3‑L1 preadipocytes were differentiated in the 
presence of 1 µM rosiglitazone for the entire culture period, 
following the same protocol.
Preparation of conditioned media (CM). To prepare the 
conditioned media of mature WAs and BAs, serum‑free 
D‑MEM/F‑12 medium with 1% BSA was added to 12‑well 
plates containing WAs or BAs and cells were incubated for 
an additional 24 h at 37˚C in 5% CO2 (24). Subsequently, 
cells were removed by centrifugation, supernatants collected, 
aliquoted and immediately stored at ‑80˚C. Control condi‑
tioned media (Ctrol‑CM) were obtained by incubating empty 
12‑well culture plates with serum‑free D‑MEM/F‑12 medium 
with 1% BSA for 24 h at 37˚C in 5% CO2. Cell‑free CM were 
used undiluted in the experiments.
Indirect immunofluorescence (IIF). Preadipocyte 3T3‑L1 
cells were grown on coverslips and differentiated into WAs 
or BAs following the protocol described above. On day 10, 
coverslips were washed with phosphate‑buffered saline 
(PBS) and adipocytes were fixed in 4% paraformalde‑
hyde‑sucrose (15 min), washed with PBS, permeabilized with 
0.5% Triton X‑100 in PBS (10 min) and blocked with high 
ionic strength buffer (20 mM Tris‑HCl pH 8.0, 0.63 M NaCl, 
1% BSA, 0.05% Tween‑20 and 0.02% sodium azide) at room 
temperature (RT) for 1 h. Cells were incubated overnight 
(ON) at 4˚C with polyclonal rabbit anti‑UCP1 (dilution 1:500; 
cat. no. U6382; Sigma‑Aldrich; Merck KGaA) or monoclonal 
mouse anti‑GLUT4 (dilution 1:50; cat. no. sc‑53566; Santa 
Cruz Biotechnology, Inc.), washed with PBS and blocked 
with 1% BSA in PBS (1 h at RT). Subsequently, coverslips 
were incubated with FITC (dilution 1:100; cat. no. F0382; 
Sigma‑Aldrich; Merck KGaA) or Alexa Fluor 647 nm (dilution 
1:100; Thermo Fisher Scientific, Inc.) conjugated secondary 
antibody for 1 h at RT. Nuclei were counterstained with Hoechst 
(cat. no. 33342; Thermo Fisher Scientific, Inc.) for 10 min. For 
the staining of LDs, coverslips were inverted onto 25 µl of 
Lipid‑TOX (dilution 1:300; HCS Lipid‑TOX™ Neutral lipid 
Stains, Invitrogen; Thermo Fisher Scientific, Inc.) following 
Hoechst staining, incubated 30 min at RT and mounted with 
Vectashield. Mitochondria were stained using MitoTracker™ 
Green FM (cat. no. M7514; Thermo Fisher Scientific, Inc.). 
Images were acquired with a Spinning Disk‑TIRF‑Olympus 
DSU‑IX83 microscope (60x objective) and analyzed using 
ImageJ software (version 1.52p; NIH). A total of 200‑300 cells 
were analyzed per condition and per experiment by two inde‑
pendent observers.
Gene expression by RT‑qPCR analysis. Total RNA was 
extracted using Tri Reagent (cat. no. TR118; Molecular 
Research Center) according to the manufacturer's instructions. 
RNA quantity and quality were assessed spectrophoto‑
metrically (NanoDrop 2000; Thermo Fisher Scientific, Inc.). 
Following reverse transcription with EasyScript Reverse 
Transcriptase (TransGen Biotech), 1 µl cDNA transcripts were 
amplified by real‑time qPCR in a StepOne Real‑Time PCR 
System in a 25 µl reaction mixture containing 12.5 µl SYBR‑
Green PCR Master Mix (both from Applied Biosystems; 
Thermo Fisher Scientific, Inc.) and the appropriate primer 
concentration. Primers used were: UCP1 forward, 5'‑GTA 
CCA AGC TGT GCG ATG TC‑3' and reverse, 5'‑ACA TGA TGA 
CGT TCC AGG AC‑3'; CIDEA forward, 5'‑TCA AAC CAT 
GAC CGA AGT AGC‑3' and reverse, 5'‑TCC AGC ACC AGC 
GTA ACC‑3'; GLUT4 forward, 5'‑TCA ACC AGC ATC TTC 
GAG TC‑3' and reverse, 5'‑AGA TGG AGT GTC CGT CGT C‑3'; 
β‑actin forward, 5'‑TGG CAC CAC ACT TTC TAC AAT‑3' and 
reverse, 5'‑GGT ACG ACC AGA GGC ATA CA‑3'. The amplifi‑
cation program used was as follows: Initial denaturation step 
at 95˚C for 10 min, 40 denaturation cycles at 95˚C for 15 sec 
and annealing and extension steps at 60˚C for 1 min. The 
expression of selected genes was normalized to that of b‑actin 
gene and the comparative ΔΔCq method (2‑ΔΔCq) (25) was used 
to calculate relative gene expression.
Western blotting (WB). WB was performed to evaluate protein 
expression levels in cell lysates and conditioned media. Cells 
were lysed in lysis buffer (60 mM Tris‑HCl, 1% SDS, pH 6.8). 
Sample protein content was determined by the Bradford 
method. Proteins (50‑80 µg) were resolved in an SDS‑PAGE 
12% gel, and electrotransferred to polyvinylidene fluoride 
membranes (PVDF) (Bio‑Rad Laboratories, Inc.). After 
blocking in 1% BSA for 1 h, the membranes were incubated 
with the different primary antibodies ON at 4˚C as follows. 
Polyclonal rabbit anti‑UCP1 (dilution 1:1,000; cat. no. U6382; 
Sigma‑Aldrich; Merck KGaA), polyclonal rabbit anti‑leptin 
(dilution 1:1,000; cat. no. ab117751; Abcam), polyclonal 
rabbit anti‑caveolin 1 (dilution 1:2,000; cat. no. 610060; BD 
Transduction Laboratories), polyclonal goat anti‑vimentin 
(dilution 1:50; cat. no. V4630; Sigma‑Aldrich; Merck 
KGaA), polyclonal rabbit anti‑perilipin 1 (dilution 1:2,000; 
cat. no. ab3526; Abcam), polyclonal rabbit anti‑HSL (dilu‑
tion 1:1,000; cat. no. ab45422; Abcam), monoclonal rabbit 
anti‑FABP4 (dilution 1:1,000; cat. no. ab219595; Abcam) 
and monoclonal mouse anti‑adiponectin (dilution 1:1,000; 
cat. no. sc‑136131; Santa Cruz Biotechnology, Inc.) antibodies 
were used to measure protein expression in mature WAs and 
BAs on day 10 and in WA‑CM and BA‑CM. Polyclonal rabbit 
anti‑MCT4 (dilution 1:500; cat. no. sc‑50329 H90; Santa Cruz 
Biotechnology, Inc.) antibody was used to measure protein 
expression in adipocyte lysates. Vimentin, polyclonal rabbit 
anti‑CD44 (dilution 1:2,000; cat. no. ab157107; Abcam), 
polyclonal rabbit anti‑ObR (dilution 1:500; cat. no. sc‑8325; 
Santa Cruz Biotechnology, Inc.), polyclonal mouse anti‑MCT1 
(dilution 1:500; cat. no. ab90582; Abcam), polyclonal goat 
anti‑MMP‑9 (1:500; cat. no. AF909; R&D Systems) and 
polyclonal rabbit anti‑LDH (dilution 1:1,000; cat. no. ab47010; 
Abcam) antibodies were used to measure protein expression 
after treatment of non‑tumor or tumor epithelial cells with CM. 
Following incubation in the primary antibody, membranes were 
washed and incubated with the corresponding HRP‑conjugated 
secondary antibody: anti‑rabbit (dilution 1:6,000; cat. no. 
A0545; Sigma‑Aldrich; Merck KGaA), anti‑goat (dilution 
1:7,500; cat. no. A5420; Sigma‑Aldrich; Merck KGaA) or 
anti‑mouse (dilution 1:4,000; cat. no. sc‑2005; Santa Cruz 
Biotechnology, Inc.). Antibody complexes were visualized 
by chemiluminescence [ECL solution containing luminol 
(cat. no. 123072; Sigma‑Aldrich; Merck KGaA), p‑coumaric 
acid (cat. no. C9008; Sigma‑Aldrich; Merck KGaA) and 
H2O2]. Bands were quantified by densitometry using ImageJ 
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software. Actin (dilution 1:1,000; cat. no. sc‑1616; Santa Cruz 
Biotechnology, Inc.) levels were used as loading control.
Oil Red O staining and analysis of triglyceride content. 
Oil Red O staining and quantification of TG content were 
performed as previously described (26) using a 0.2% Oil 
Red O solution in 40% 2‑propanol. After staining, cell images 
were captured in an inverted phase‑contrast microscope 
(Olympus CKX‑41; objective 20x) and the average number of 
LDs per cell recorded in WAs and BAs using ImageJ soft‑
ware. TG content was quantified by incubating culture plates 
in 100% 2‑propanol for 10 min at RT on an orbital shaker to 
elute the Oil Red O dye. The eluted dye was transferred to 
a 96‑well plate and the absorbance was measured at 510 nm 
using a multimodal microplate reader (Synergy HTX S1LFA 
S/N 18062619; BioTek Instruments). Assay was performed in 
quadruplicate.
Measurement of lactate in conditioned media. To quantify 
extracellular lactate released by mature WAs and BAs 
on day 10, CM were obtained from adipocytes incubated 
with D‑MEM/F‑12, 1% BSA for 24 h. Supernatants were 
recovered, and cell debris was removed by centrifugation. 
Lactate was measured by a standard method involving the 
conversion of NAD+ to NADH and subsequent spectropho‑
tometric determination of NADH at 340 nm. A commercial 
kit (Sigma‑Aldrich; Merck KGaA) was used to carry out the 
determination as indicated by the manufacturer. Results are 
expressed as µg of lactate/100 µl.
Cell adhesion assay. The adhesion capacity of cell lines was 
analyzed following treatment with WA‑CM or BA‑CM. For this 
purpose, 1x105 cells/well of non‑tumor mammary epithelial 
cell lines (NMuMG) or tumor cells (LM3, 4T1 and MC4‑L1) 
were seeded in 12‑well plates in D‑MEM/F‑12 supplemented 
with 10% FBS. Twenty‑four hours later, the cells were washed 
with PBS and incubated for another 24 h with WA‑CM, 
BA‑CM or Ctrol‑CM. Cells were then harvested and re‑seeded 
in duplicate or triplicate in a 96‑well plate (5x104 cells/well). 
After 1 h, medium containing the unattached cells was 
aspirated, adhered cells washed with PBS and, 3 h later, adhe‑
sion was assessed by the MTS assay measuring absorbance 
at 490 nm in a multimodal microplate reader (Synergy HTX 
S1LFA S/N 18062619; BioTek Instruments).
Cell migration assays.
Wound healing assay. The effect of WA‑CM or BA‑CM on 
the motility of tumor and non‑tumor mammary epithelial cell 
lines was evaluated by wound healing assays. NMuMG, LM3, 
4T1 and MC4‑L1 cells were grown on 96‑well plates with 
supplemented D‑MEM/F‑12 until cells reached 100% conflu‑
ence. Afterwards, cell monolayers were scratched with a 200‑µl 
pipette tip, washed twice with PBS and WA‑CM, BA‑CM 
or Ctrol‑CM were added to the wells. CM were obtained as 
previously described in a serum‑free D‑MEM/F‑12 medium 
with 1% BSA and used undiluted. Images at time zero (0 h) 
were obtained to record the initial width of the wounds, and 
the recovery of the wounded area was evaluated at 6 and 12 h. 
Images of the wound closure were captured using an inverted 
microscope (Olympus CKX‑41; objective 4x), quantitative 
analysis of wounds was performed by ImageJ software and 
the relative wound closure was calculated with respect to 0 h.
Transwell migration assay. The effect of WAs or BAs on the 
motility of tumor and non‑tumor mammary epithelial cells 
was analyzed by Transwell migration assay. NMuMG, LM3, 
4T1 and MC4‑L1 mammary cell lines (1.5x104 cells/well) were 
placed into Transwells [8‑µm pore membrane (top); Jet BIOFIL 
cat. no. TCS‑013‑024] containing serum‑free D‑MEM/F‑12 
1% BSA medium. The inserts were immediately transferred to 
24‑well plates with mature WAs or BAs at the bottom of the 
well. Given that LM3 and 4T1 epithelial cells have a high basal 
migration rate whereas NMuMG and MC4‑L1 cell lines present 
a very low basal migration rate, Transwell migration assays 
were performed for 6, 12 and 24 h in all mouse mammary 
cells studied. After tumor and non‑tumor mammary epithelial 
cells were allowed to migrate across the membrane, the inserts 
were removed, washed with PBS, and the mammary cells were 
fixed with cold methanol for 30 min, washed with PBS and 
stained with Hoechst (cat. no. 33342; Thermo Fisher Scientific, 
Inc.) 1 µg/ml for 10 min and non‑migrating cells were removed 
with a wet cotton. Air‑dried membranes were imaged at x40 
magnification under an inverted microscope (Olympus CK‑41) 
and migrated cells were counted in 10 randomly chosen fields 
per membrane with ImageJ software.
Statistical analysis. Experiments were repeated at least twice 
with similar results. Data are presented as mean ±SEM. 
Student's t‑test, the Mann‑Whitney test or one‑way analysis of 
variance (ANOVA) followed by Tukey's multiple comparison 
test was performed as needed. Differences were considered 
significant at P<0.05.
Results
Characteristics of the WAs and BAs differentiated from 
3T3‑L1 preadipocytes. Indirect immunofluorescence was 
performed in 3T3‑L1 adipose cells to assess the expression 
and localization of beige markers. As expected, the presence 
of 1 µM rosiglitazone (Rosi), a specific agonist of peroxisome 
proliferator‑activated receptor γ (PPARγ), in the differentia‑
tion cocktail significantly increased the expression of UCP1 
(Fig. 1A, bottom panels). UCP1 showed a punctate staining 
pattern like the one observed with Mitotracker (Fig. 1A vs. B, 
bottom panels). Interestingly, BAs displayed round‑shaped 
mitochondria, suggesting sustained fission activity (Fig. 1B, 
white arrow head in bottom panels), while WAs showed a mix 
of tubular (white arrow in top panels, Fig. 1B) and partially frag‑
mented mitochondria (white arrow head in top panels Fig. 1B). 
Fragmented mitochondria with round‑shaped morphology 
were not found in undifferentiated 3T3‑L1 preadipocytes 
treated with rosiglitazone (Fig. 1B, bottom panels, a fibroblast 
adjacent to an adipocyte occupies the bottom right in first 
panel and can be seen at higher magnification in third panel), 
excluding an effect of PPARγ activation on fission events.
There is evidence that brown/beige adipocytes express 
high levels of GLUT4, and consume glucose at significantly 
higher levels (20,27). An increase in GLUT4 fluorescence 
intensity was observed in BAs in comparison to WAs (Fig. 1C, 
bottom vs. top panels), and BAs showed an increase in the 
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number of micro‑LDs (Fig. 1D, +Rosi) but a decrease in TG 
accumulation compared to WAs (Fig. 1E +Rosi vs. ‑Rosi).
Expression levels of beige markers and GLUT4, leptin and 
MCT4 were measured in WAs and BAs differentiated from 
3T3‑L1 preadipocytes. The increased fluorescence intensity of 
UCP1 and GLUT4 previously observed in BAs was confirmed 
by RT‑qPCR (Fig. 2A). The expression of Ucp1, Cidea (another 
classic beige/brown marker), and Glut4 was significantly higher 
in 3T3‑L1 adipose cells after PPARγ activation. Expression 
levels of UCP1, HSL, perilipin 1, adiponectin, leptin, FABP4, 
caveolin 1, vimentin and the metabolic markers MCT4 and 
LDH were evaluated in WAs and BAs (Fig. 2B). Perilipin 1, 
the main protein coat for LDs in mature adipocytes, and HSL 
are two proteins involved in the lipolytic process.
Perilipin 1 expression was slightly decreased in the BAs 
compared to the WAs; HSL levels were not affected by 
rosiglitazone treatment. Adiponectin and leptin are the main 
adipokines released by adipocytes; worthy of note, there was 
a higher leptin expression but significantly lower adiponectin 
expression in BAs when compared to the WAs (Fig. 2B). 
Caveolin‑1 is an important protein, necessary for LD forma‑
tion (28), and a marked decrease in caveolin 1 expression was 
observed in the BAs (Fig. 2B), in agreement with a decrease in 
lipid accumulation (Fig. 1E). The expression of FABP4, actively 
secreted and essential to modulate lipid fluxes, trafficking, 
signaling and metabolism in adipocytes, was increased in BAs, 
while a decrease in vimentin expression was observed in BAs 
when compared to WAs (Fig. 2B). The expression of MCT4, 
a mediator of lactate export, was increased in BAs relative to 
WAs (Fig. 2B); expression levels of LDH, enzyme catalyzing 
the conversion of pyruvate to lactate, were similar to those of 
MCT4 (data not shown).
Expression of leptin, FABP4, UCP1, adiponectin, caveolin 1 
and vimentin and lactate efflux in WA‑CM and BA‑CM. To 
characterize soluble factors present in WA‑CM and BA‑CM, 
the expression levels of different proteins were determined by 
WB. According to Fig. 3A and B, the results showed signifi‑
cantly increased expression of leptin in BA‑CM compared to 
WA‑CM, while adiponectin and caveolin 1 expression was 
significantly decreased. Vimentin was present in both WA‑ 
and BA‑CM, but the expression levels were not significantly 
different. Increased expression of FABP4 and UCP1 was found 
in BA‑CM in comparison to WA‑CM. Worthy of note, changes 
in expression levels of leptin, adiponectin, caveolin 1, UCP1 
and FABP4 in CM (Fig. 3A and B) agree with those observed 
in the cellular extracts (Fig. 2B). Expression levels of HSL 
(Fig. 3A) and perilipin 1 (data not shown) were insignificant 
in both CM.
We investigated whether the upregulation of MCT4 
and LDH upon differentiation into BAs translated into an 
Figure 1. Characteristics of WAs and BAs differentiated from 3T3‑L1 preadipocytes. (A and C) Expression and localization of UCP1 and GLUT4, and 
localization of lipid droplets (LDs) were evaluated by IIF. 3T3‑L1 preadipocytes were grown on coverslips and induced to differentiate into WAs (3T3‑L1 
adipocytes‑Rosi) or BAs (3T3‑L1 adipocytes +Rosi) using 1 µM rosiglitazone (Rosi). On day 10, adipocytes were fixed and incubated with the indicated 
antibodies. Nuclei were counterstained with Hoechst. Images were analyzed by confocal microscopy (magnification, x600). (B) WAs or BAs were incubated 
with 200 nM MitoTracker Green for 15 min followed by wash‑out before imaging. White arrow heads show examples of round‑shaped mitochondria and white 
arrows show examples of tubular mitochondria. Boxed areas are shown as zoomed images on right (zoom). LD, lipid droplet; N, nuclei. (D) LDs in WAs or BAs 
were stained with Lipid‑TOX. The average number of LD per cell was quantified in WAs and BAs using ImageJ software (version 1.52p; NIH). Representative 
confocal microscopy images are shown. (E) 3T3‑L1 cells differentiated into WAs or BAs, were stained with Oil Red O and images were acquired in a phase 
contrast microscope. Representative light microscopy images (magnification, x200) are shown. TG content in WAs and BAs was quantified by measuring 
the absorbance of extracted lipid stain at 510 nm. (n=4‑5 experiments in triplicate). Mann‑Whitney test was performed; **P<0.01 and ***P<0.001, compared 
with the ‑Rosi group. Rosi, rosiglitazone; WAs, white adipocytes; BAs, beige adipocytes; TG, triglyceride; UCP1, uncoupled protein 1; GLUT4, glucose 
transporter 4; IIF, indirect immunofluorescence. 
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increased lactate flux. Lactate efflux from WAs and BAs, 
evaluated in WA‑ and BA‑CM using a colorimetric assay, 
showed that lactate transporter capacity was increased in 
3T3‑L1 differentiated into a beige phenotype (Fig. 3C).
Effect of BA‑CM on cellular adhesion of mammary epithelial 
cells. To compare the presence of soluble factors in WA‑CM 
and BA‑CM, that could affect tumor cell adhesion, NMuMG, 
LM3, 4T1 and MC4‑L1 epithelial cells were exposed to 
different CM (WA‑, BA‑ or Ctrol‑CM) and cell adhesion was 
determined as described in Materials and methods. WA‑CM 
and BA‑CM significantly decreased adhesion of LM3, 4T1 and 
MC4‑L1 cells with respect to Ctrol‑CM (Fig. 4). On the other 
hand, NMuMG cell adhesion was decreased significantly after 
incubation with BA‑CM vs. both WA‑CM and Ctrol‑CM.
Effect of BA‑CM on tumor and non‑tumor mammary epithelial 
cell migration. To evaluate the effect of WA‑CM and BA‑CM 
on the migratory capacity of tumor and non‑tumor mammary 
epithelial cells, we performed wound healing assays. WA‑CM 
and BA‑CM significantly increased migration of LM3 and 
4T1 (tumor) cells after incubating for 6 h, and of MC4‑L1 
(tumor) and NMuMG (non‑tumor) after incubating for 12 h 
vs. the Ctrol‑CM (Fig. 5). These results suggest that BA‑CM 
Figure 4. Effect of CM from WAs and BAs on the attachment of NMuMG, LM3, 4T1 and MC4‑L1 cells. Non‑tumor (NMuMG) and tumor (LM3, 4T1 and 
MC4‑L1) epithelial cells were treated with WA‑CM, BA‑CM or Ctrol‑CM for 24 h. After treatment, the cells were plated at a density of 5x104 cells/well in 
96‑well plates and adherent cells were quantified by MTS after 1 h (n=2 experiments in triplicate). Tukey's multiple comparison test was performed; *P<0.05, 
**P<0.01 and ***P<0.001, compared with the Ctrol‑CM group. WA, white adipocyte; BA, beige adipocyte; CM, conditioned media.
Figure 3. Expression levels of a different set of proteins in WA‑CM and BA‑CM. (A and B) Leptin, adiponectin, caveolin 1, FABP4, vimentin, UCP1 and HSL 
expression was analyzed by WB and images were analyzed by densitometry. (C) The levels of lactate secreted by WAs or BAs were determined by colorimetric 
assay (WA‑CM and BA‑CM collected after 24 h of incubation) (n=3 experiments in triplicate). Mann‑Whitney test was performed; *P<0.05 and **P<0.01, 
compared with WA‑CM. WB, western blotting; WA, white adipocyte; BA, beige adipocyte; CM, conditioned media; UCP1, uncoupled protein 1; FABP4, fatty 
acid binding protein 4; HSL, hormone‑sensitive lipase.
Figure 2. Expression levels of different brown/beige/white adipocyte markers. (A) 3T3‑L1 preadipocytes were differentiated into WAs or BAs (3T3‑L1 
adipocytes ‑Rosi or +Rosi, respectively). On day 10, mRNA was extracted for the RT‑qPCR analysis of Ucp1, Cidea and Glut4, and (B) protein was extracted 
for immunoblot analysis of the expression of UCP1, HSL, perilipin 1, leptin, adiponectin, caveolin 1, MCT4, vimentin, and FABP4. Actin was used as a loading 
control. (n=3‑4 experiments in triplicate). Mann‑Whitney test was performed; **P<0.01 and ***P<0.001, compared with the ‑Rosi group. WAs, white adipocytes; 
BAs, beige adipocytes; UCP1, uncoupled protein 1; Cidea, cell death‑inducing DFFA‑like effector A; GLUT4, glucose transporter 4; FABP4, fatty acid binding 
protein 4; MCT4, monocarboxylate transporter 4; HSL, hormone‑sensitive lipase.
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increase the migration capacity of both tumor and non‑tumor 
mammary epithelial cells in agreement with results found in 
the cell adhesion assays (Fig. 4).
Transwell migration of tumor cells in the presence of BAs. 
To compare the chemotactic capacity of BAs and WAs on 
tumor and non‑tumor epithelial cell migration, Transwell 
migration assays were performed as described in Materials 
and methods. BAs significantly increased cell migration of 
LM3 and MC4‑L1 cells vs. the WAs, following incubation for 
6 and 24 h, respectively (Fig. 6). BAs also increased 4T1 cell 
migration after incubation for 6 h though to a lesser extent, but 
there was no significant chemotactic effect of BAs or WAs on 
NMuMG migration at any time tested.
Taken together, these results suggest that crosstalk takes 
place between tumor cells and BAs and that this cell‑cell 
communication may be necessary to modulate adipocyte 
action on epithelial cell migration, beyond the effect of 
soluble factors.
Effect of soluble factors from WAs and BAs on ObR, CD44, 
vimentin, MMP‑9, MCT1 and LDH expression level in 
NMuMG, 4T1, LM3 and MC4‑L1 cell lines. The effect of 
soluble factors released by WAs and BAs on the expression 
level of several tumor progression markers, was evaluated by 
WB in tumor and non‑tumor epithelial cells incubated with 
WA‑CM, BA‑CM or Ctrol‑CM for 24 h. ObR and MMP‑9 
expression in MC4‑L1 cells was significantly higher when 
incubated with BA‑CM compared to WA‑CM or Ctrol‑CM 
(Fig. 7, MC4‑L1). CD44 expression showed an increasing trend 
in MC4‑L1 cells incubated with BA‑CM (Fig. 7, MC4‑L1), but 
differences were not significant. By contrast, MMP‑9 expres‑
sion was significantly lower when NMuMG (non‑tumor) cells 
were treated with BA‑CM and WA‑CM vs. Ctrol‑CM and, 
interestingly, CD44 and ObR expression levels were signifi‑
cantly decreased in LM3 and 4T1, respectively, after treatment 
with WA‑CM. Vimentin expression level was not affected by 
different CM treatments and, surprisingly, neither were MCT1 
and LDH expression levels (Fig. 7).
Discussion
Bidirectional communication between epithelial cells and 
cells from the stromal compartment is essential for tumor 
Figure 5. Effect of CM from WAs and BAs on the migration of NMuMG, LM3, 4T1 and MC4‑L1 cells. Non‑tumor (NMuMG) and tumor (LM3, 4T1 
and MC4‑L1) epithelial cells were grown to confluence on 96‑well plates in the presence of complete D‑MEM/F‑12 medium. Wounds were formed, and 
WA‑CM, BA‑CM or Ctrol‑CM were added. Images of the wound closure were acquired immediately after the wound was made (0 h), and after 6 and 12 h. 
Representative zoomed areas from light microscopy images (magnification, x40) are shown. Graph shows the ratio of 12/0 h (NMuMG and MC4‑L1) or 6/0 h 
(LM3 and 4T1) wounded areas (n=3 experiments in duplicate). Tukey's multiple comparison test was performed; *P<0.05, **P<0.01 and ***P<0.001, compared 
with the Ctrol‑CM group. WA, white adipocyte; BA, beige adipocyte; CM, conditioned media.
Figure 6. Chemotactic capacity of WAs and BAs on migration of non‑tumor and tumor epithelial cells. Non‑tumor (NMuMG) and tumor (LM3, 4T1 and 
MC4‑L1) epithelial cells were added in the top chamber onto the porous membrane, and were allowed to migrate across the membrane towards WAs or BAs 
present in the bottom chamber, for 6, 12 or 24 h. The membranes were viewed under a light microscope (magnification, x40). Migrated cells were counted 
in 10 randomly chosen fields per membrane (n=2 experiments in triplicate). Student's t‑test was performed; *P<0.05, **P<0.01, compared with the WA group. 
WAs, white adipocytes; BAs, beige adipocytes.
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development and maintenance of a cancerous phenotype, 
whether invasive or not (2,29). This crosstalk can either 
trigger cancerous behavior and support it or, eventually, lead 
to involution to a non‑tumor form. Invading cancer cells can 
dramatically impact the surrounding adipose cells that exhibit 
an altered phenotype and specific biological features (e.g. lipid 
loss and overexpression of inflammatory cytokines) suggesting 
that adipose cells in the tumor environment present a less 
differentiated state than adipocytes in a normal microenviron‑
ment (3,30‑32). Multiple lines of evidence obtained in vitro 
and in vivo have demonstrated that an increased expression of 
beige/brown adipose tissue key markers occurs during breast 
tumor development (16,18,21) and this, is in turn, promotes 
tumor progression (19,33). In the present study, we evaluated 
the possible role of beige adipocytes (BAs) in the control of 
mammary epithelial cell pathophysiology.
We characterized the cell phenotype of mouse BAs 
obtained in vitro after treatment of 3T3‑L1 preadipocytes 
with rosiglitazone, a known peroxisome proliferator‑acti‑
vated receptor γ (PPARγ) activator which has been described 
as acting in vivo in mouse white fat depots (34). Our results 
showed that upon PPARγ activation, 3T3‑L1 adipocytes 
displayed multilocular micro‑lipid droplet (LD) morphology 
and expressed brown fat‑specific genes such as Ucp1 and 
Cidea. The shift in adipocyte phenotype (white to beige) 
involves marked changes in the metabolic state of mitochon‑
dria (35). Accordingly, our results showed UCP1‑positive 
mitochondria preferentially displaying a round shape (mito‑
chondrial fission), whereas UCP1‑negative mitochondria 
appeared tubular and elongated, in agreement with previous 
findings in mice and human brown/beige adipocytes (36‑38). 
Thus, mitochondrial fission in 3T3‑L1 BAs may be considered 
a physiological adaptation rather than a purely deleterious 
mechanism (36).
The pathways mainly regulated by rosiglitazone in 3T3‑L1 
adipocytes are fatty acid oxidation, the TCA cycle and oxida‑
tive phosphorylation. Rosiglitazone induces adipocytes to 
utilize fatty acids for energy production, increasing lipolysis 
and reducing lipogenesis, and spare glucose and amino acids 
by enhancing glycogen synthesis and inhibiting amino acid 
catabolic pathways. This is in line with the upregulation of 
UCP1 and downregulation of perilipin 1 observed in this study, 
which thus act as gatekeepers of lipolysis regulation. Increased 
levels of UCP1 correlate with a shift in substrate utilization, 
favoring lipids as the dominant metabolic fuel (10,39).
Metabolic reprogramming is an emerging hallmark of 
cancer (40,41). There is evidence that suggests that the expres‑
sion of monocarboxylate transporters (MCTs), mediators of 
lactate flux, is modified when metabolic demands of the tissue 
are being altered (42), and that MCT upregulation is impor‑
tant for the normal physiological function of mature adipose 
cells (43). Our results showed that both MCT4 expression and 
lactate flux capacity were increased in BAs. MCT1 and MCT4 
have now been confirmed as prominent facilitators of lactate 
exchange between cancer and stromal cells (44,45). In fact, 
it is likely that an elevated expression of MCT4 in stromal 
adipose tissue concomitantly with MCT1 overexpression in 
malignant tissue, may be an important clinical biomarker for 
poor prognosis in breast cancer patients (19,45).
Cancer cells take up free fatty acids and glycerol, besides 
glucose, as a source of energy from adjacent adipocytes. Thus, 
BAs could pose as an important energy storage providing 
tumor cells with high energy metabolites such as lactate, a 
situation known as the reverse Warburg effect (46,47). Our 
Figure 7. Effect of CM from WAs and BAs on the expression levels of several tumor progression and metabolic markers was evaluated in mammary epithelial 
cells. Non‑tumor and tumor cells were grown on 6‑well plates, incubated for 24 h with the different CM and, then, lysed. The expression of ObR, CD44, 
vimentin, MMP‑9, MCT1 and LDH was analyzed by WB. Actin was used as a loading control. Images were analyzed by densitometry (n=2 experiments in 
triplicate). Tukey's multiple comparison test was performed; *P<0.05, **P<0.01 and ***P<0.001, cells incubated with WA‑CM or BA‑CM vs. Ctrol‑CM; ##P<0.01 
and ###P<0.001, cells incubated with BA‑CM vs. WA‑CM. WA, white adipocyte; BA, beige adipocyte; CM, conditioned media; MCT1, monocarboxylate 
transporter 1; ObR, leptin receptor; MMP‑9, matrix metalloprotease 9; LDH, lactate dehydrogenase.
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results showed no significant differences in the expression 
levels of MCT1, a key transporter for the uptake of lactate 
into cells, when tumor or non‑tumor epithelial cells were 
incubated with beige adipocyte‑conditioned media (BA‑CM). 
However, the possibility that lack of response in our study was 
due to the experimental setup cannot be ruled out. Additional 
studies examining the effect of white adipocyte (WA)‑CM and 
BA‑CM and adipocyte‑epithelial cell co‑culture on intracel‑
lular signaling pathways of non‑tumor and tumor epithelial 
cells are currently in progress.
Adipokines, secreted in large amounts by adipose tissue, 
can act in an autocrine, paracrine, and/or endocrine manner 
to control various cellular processes, including those involved 
in the aggressive biological behavior of breast cancers (48). 
Adiponectin and leptin are the two main adipokines secreted by 
adipocytes. Plasma leptin levels are increased in breast cancer 
patients, correlating with higher grade, advanced tumor stage 
and aggressive subtypes (49) and leptin expression is increased 
in breast cancer peritumoral stroma (50). Leptin, by binding to 
the leptin receptor (ObR), promotes proliferation and develop‑
ment of breast cancer cells (49). Serum adiponectin levels seem 
to be significantly decreased in breast cancer patients, while 
antiproliferative effects of adiponectin, cell cycle inhibition 
and apoptosis activation have been verified (49). We previously 
reported a decrease in adiponectin expression in peritumoral 
adipose tissue compared to adipose tissue distant from the 
tumor (3). The present results revealed that leptin synthesis 
and secretion were increased in BAs, while adiponectin was 
decreased, further supporting the contention that the presence 
of BAs within breast cancer peritumoral adipose tissue could 
contribute to adipokine imbalance observed in the tumor 
microenvironment.
Fatty acid binding protein 4 (FABP4), a fatty acid trans‑
port protein, is another important adipokine that can regulate 
systemic metabolism (51,52) and could be involved in cancer 
cell growth and metastasis (29,52). Guaita‑Esteruelas et al 
proposed that exogenous FABP4, which is responsive to 
signals that induce lipolysis, facilitates the uptake of fatty acids 
into breast cancer cells, playing a key role in tumor progres‑
sion (53,54). On the other hand, Witkiewicz et al showed that 
a reduction or loss of stromal caveolin 1 expression is usually 
associated with increased risk of early tumor recurrence, 
metastasis and decreased overall survival (55). Our results 
showed increased FABP4 expression and decreased caveolin 1 
in BAs which, taken together with an increased mobility of 
fatty acids induced by UCP1 activation (56), suggest that BA 
tissue could promote tumor cell progression. Worthy of note, 
upregulation of UCP1 is considered a hallmark of metabolic 
stress associated with poor survival in breast cancer (19,57,58).
The ability of WA‑CM to modify breast tumor progres‑
sion has been reported in several studies (19,24). Interestingly, 
in this study, incubation of LM3, 4T1 and MC4‑L1 (tumor) 
cells with both BA‑CM or WA‑CM produced a significant 
decrease in cell adhesion and increase in cell migration vs. 
Ctrol‑CM. However, when chemotactic capacity of BAs and 
WAs on tumor and non‑tumor epithelial cell migration was 
evaluated, BAs significantly increased cell migration in LM3 
and MC4‑L1 cell lines vs. WAs, suggesting that the presence 
of BAs modified the microenvironment promoting migration 
of epithelial cells. Adipose cells are known to affect tumor 
properties through various signaling processes, a crosstalk 
that can only happen when both cell types are in close contact 
during tumor progression and metastasis formation (2,59). 
Supporting our results, Wu et al proposed that the preliminary 
step in this close interaction could be the capacity of tumor 
cells to induce this beige/brown differentiation and lipolysis 
in adipose cells (19). The effect of BA‑CM on cell adhesion 
of NMuMG (non‑tumor) cells was significantly higher than 
WA‑CM, suggesting that soluble factors of WA‑CM and 
BA‑CM had a differential effect on non‑tumor epithelial cells.
Despite the fact that there were no significant differences 
between BA‑CM and WA‑CM effects on cell adhesion and 
migration in tumor cells, MC4‑L1 cells showed higher ObR 
and MMP‑9 expression levels after incubation with BA‑CM 
compared to WA‑CM or Ctrol‑CM. The invasion of tumor 
cells into healthy tissues is promoted by a necessary local 
proteolysis of the extracellular matrix (ECM), which involves 
the activity of metalloproteases (MMPs) (60). MMP‑2 
and MMP‑9 play a fundamental role in proteolytic matrix 
degradation during invasion and metastasis, and an increase 
in MMP‑2 and MMP‑9 in human breast tumors has been 
associated with poor patient prognosis (60). Increased expres‑
sion of MMP‑9 in MC4‑L1 cells could thus favor degradation 
of the basement membrane, an essential early step in tumor 
invasion. In agreement with this result, BA‑CM also increased 
the expression of CD44 in the MC4‑L1 cell line, a membrane 
glycoprotein involved in tumor cell migration and invasion 
processes (61,62). We have recently shown that incubation of 
MCF7 and IBH‑7 cells with CM from human breast cancer 
adipose tissue explants, stimulates the expression of CD44 (3). 
Taken together, our results indicate that one or more soluble 
factors present in CM from BAs could increase the subpopula‑
tion of MC4‑L1 cells with high levels of CD44 and MMP‑9, 
promoting cellular migration and consequently inducing 
cancer cell invasion. This evidence is clinically significant 
given that MC4‑L1 cells are a luminal breast cancer model and 
luminal type accounts for more than 30‑45% of breast cancers. 
Further studies are necessary to determine whether there is 
crosstalk signaling between BAs and molecular subtypes of 
breast cancer cells. Knockdown of CD44 and ObR genes in 
LM3 and MC4‑L1 epithelial cells would lead us to achieve a 
more detailed comprehension of BA function in breast cancer 
progression. We are trying to solve this experimental limita‑
tion in a current study, trying to understand whether BAs are 
key actors in breast cancer development and maintenance of a 
cancerous phenotype.
Taken together, the results obtained in this study encourage 
us to speculate that breast cancer cells could increase 
BA recruitment or induce beige/brown differentiation in 
surrounding white fat, as a strategy to reduce energy storage 
in adipocytes which would then be acting as a metabolic fuel 
source. Additionally, given the ability of brown adipocytes to 
secrete soluble factors, which can promote angiogenesis (63) 
and rearrangement of the extracellular environment (64), BAs 
in the invasive front of breast tumors could enhance tumor 
growth indirectly by stimulating angiogenesis/remodeling of 
ECM as a consequence of promoting tumor cell invasion.
The main challenge for future studies will be to identify 
the pathway through which BAs regulate breast cancer devel‑
opment. Since tumor cells co‑cultured with BAs exhibit an 
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aggressive phenotype, we propose to evaluate the effect of 
BA‑CM and BA‑epithelial cells, in direct co‑culture, on both 
morphological and metabolic changes, and activation of cancer 
stem cell signaling.
In conclusion, this study demonstrates that there are 
profound changes in protein expression and mitochondrial 
modifications during differentiation of 3T3‑L1 preadipocytes 
into BAs, and that mitochondrial fission, which has been 
described in human brown adipose cells, also occurs in a 
mouse model (11). We propose that PPARγ activation of 
3T3‑L1 adipocytes could be an interesting model to study 
bidirectional communication between epithelial cells and 
BAs and how the latter participate in the development and 
progression of breast cancer.
Understanding the key signaling pathways in beige/brown 
adipose cells that might contribute to breast tumor progres‑
sion will most certainly contribute to the development of novel 
therapeutic strategies to control breast tumor growth.
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